Alerts will be sent to your verified email
Verify EmailSHIVALIK
|
Shivalik Rasayan
|
Kilitch Drugs(India)
|
Prevest Denpro
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Chemicals
|
|||
|
Capacity Utilization - Dimethoate
|
95.0 % | n/a | n/a |
|
Realization/Tonne - Dimethoate
|
299080.92 Rs/MT | n/a | n/a |
|
Realization/Tonne - Sodium hydrosulfide
|
4487.46 Rs/MT | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
6.54 % | 7.31 % | 19.0 % |
|
5yr average Equity Multiplier
|
1.82 | 1.48 | 1.07 |
|
5yr Average Asset Turnover Ratio
|
0.44 | 0.56 | 0.6 |
|
5yr Avg Net Profit Margin
|
7.94 % | 8.44 % | 29.64 % |
|
Price to Book
|
1.04 | 2.25 | 4.63 |
|
P/E
|
43.48 | 21.67 | 27.26 |
|
5yr Avg Cash Conversion Cycle
|
100.7 Days | 14.76 Days | 42.6 Days |
|
Inventory Days
|
80.64 Days | 14.42 Days | 36.0 Days |
|
Days Receivable
|
107.04 Days | 136.16 Days | 44.41 Days |
|
Days Payable
|
166.18 Days | 212.73 Days | 39.32 Days |
|
5yr Average Interest Coverage Ratio
|
8.55 | 6.02 | 99.71 |
|
5yr Avg ROCE
|
8.54 % | 11.26 % | 25.39 % |
|
5yr Avg Operating Profit Margin
|
17.6 % | 12.28 % | 36.91 % |
|
5 yr average Debt to Equity
|
0.2 | 0.17 | 0.0 |
|
5yr CAGR Net Profit
|
-1.04 % | 48.72 % | 2.94 % |
|
5yr Average Return on Assets
|
3.57 % | 4.99 % | 17.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
47.37 % | 63.77 % | 73.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.95 % | -4.48 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shivalik Rasayan
|
Kilitch Drugs(India)
|
Prevest Denpro
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|